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a b s t r a c t
Noroviruses (NoVs), an important cause of gastroenteritis in humans, recognize human histo-blood
group antigens (HBGAs) as receptors. The crystal structures of the protruding (P) domain of a GII.10 NoV
(Vietnam 026) in complex with various HBGA oligosaccharides were elucidated. However, the HBGA
binding proﬁle of this virus remains unknown. In this study, we determined the saliva and oligosacchar-
ide binding proﬁles of this virus and the roles of amino acids that are involved in HBGA binding. Our data
showed that Vietnam 026 bound to all ABO secretor and non-secretor saliva with clear signals detected
by monoclonal antibodies against H3, H1, Ley, Lea and sialyl Lea. Mutagenesis study conﬁrmed the
binding site determined by the crystallography study, in which single mutations wiped out the binding
function. We also identiﬁed amino acids surrounding the central binding pocket that may participate in
the binding by affecting the HBGA binding speciﬁcity of the GII.10 NoV.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Noroviruses (NoVs), a group of small-and-round structured
RNA viruses constituting Norovirus genus in the family Calicivir-
idae, are a major cause of epidemic and sporadic acute gastro-
enteritis in humans. In the United States, NoVs cause19–21 million
cases of acute gastroenteritis annually (Hall et al., 2013; Scallan
et al., 2011). Structurally NoVs are non-enveloped viruses with
protein capsids that encapsulated a single-stranded, positive-
sense, polyadenylated RNA genome of 7.5 kb. The NoV genome
contains three open reading frames (ORFs). ORF1 encodes a large
polyprotein that is post-translationally cleaved into six nonstruc-
tural proteins, while ORF2 and 3 encodes the major (VP1) and the
minor (VP2) structural proteins, respectively.
NoV capsid comprises a single major structural protein (VP1) that
is divided into two principal domains, the shell (S) and the protruding
(P) domains. While the S domain forms the interior, icosahedral shell,
the P domain constitutes the protruding spikes extending from the
shell (Prasad et al., 1999). The S and the P domains can be structura-
lly and functionally independent. Expression of the S domain alone
results in thin layer, icosahedral S particles, corresponding to interior
shell of the capsid without the protruding P domains (Bertolotti-
Ciarlet et al., 2002; Tan et al., 2004a). On the other hand, the P domain
alone can form different complexes, including 24 mer P particles (Tan
et al., 2008a; Tan et al., 2011b; Tan and Jiang, 2005b), 12 mer small P
particles (Tan et al., 2011a) and P dimers (Tan et al., 2004a; Tan et al.,
2008c). These P domain complexes are interchangeable in certain
condition (Bereszczak et al., 2012) and they all bind to histo-blood
group antigens (HBGAs) (Tan et al., 2011a; Tan et al., 2004a; Tan and
Jiang, 2005b), the viral receptors or attachment factors of NoVs (Tan
and Jiang, 2005a, 2007, 2010, 2011). NoV P domain complexes have
been useful tools for study of NoV–HBGA interactions (Tan et al.,
2004a; Tan et al., 2008b; Tan et al., 2006; Tan et al., 2008c; Tan et al.,
2009).
NoVs recognize HBGAs in a strain-speciﬁc manner and eight HBGA
binding proﬁles of NoVs have been observed (Huang et al., 2003;
Huang et al., 2005). HBGAs are complex carbohydrates present
abundantly on mucosal epithelia of gastrointestinal track where they
serve as receptors or attachment factors for NoVs to initiate infections.
In addition, HBGAs also exist as free antigens in biologic ﬂuids,
including blood, saliva and milk. Increasing data showed that NoV–
HBGA interactions play an important role in the host susceptibility of
NoVs (Frenck et al., 2012; Hutson et al., 2002; Lindesmith et al., 2003;
Tan and Jiang, 2010, 2011; Tan et al., 2008b). The HBGA binding sites
have been mapped on the tops of the P dimers and the structural
bases of NoV–HBGA interactions and have been elucidated in detail by
crystallography (Bu et al., 2008; Cao et al., 2007; Chen et al., 2011; Choi
et al., 2008; Hansman et al., 2011; Kubota et al., 2012; Shanker et al.,
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2011; Shanker et al., 2014) and by site-directed mutagenesis
(de Rougemont et al., 2011; Tan et al., 2008c; Tan et al., 2009). These
extensive structural studies provide solid foundation to understand
the complex interactions between the diverse NoVs and the poly-
morphic HBGAs, including ABO, Lewis and secretor antigens (Tan and
Jiang, 2010, 2011, 2014).
The association of the host susceptibility of NoVs with their
HBGA binding proﬁles has been shown by the human challenge
studies on the prototype Norwalk virus (GI.1) (Hutson et al., 2002;
Lindesmith et al., 2003) and the two GII.4 NoVs (Frenck et al., 2012).
Similar associations have also been shown through outbreak
investigations (Carlsson et al., 2009; Kindberg et al., 2007; Tan
et al., 2008b; Thorven et al., 2005). In contrast to the predominant
GII.4 NoVs, GII.10 NoVs represent a rare genotype. However, a recent
crystallography study showed that a GII.10 NoV, named Vietnam
026, interacts with all ﬁve secretor HBGAs, including A, B, H, Leb,
and Ley antigens (Hansman et al., 2011), raising a question on the
spectrum of HBGA-binding proﬁle of this NoV and the association of
the spectrum with the host susceptibility and prevalence of this
NoV. To address these questions we determined the HBGA-binding
speciﬁcity of Vietnam 026 through conventional saliva and
oligosaccharide-based Elisa and conﬁrmed major data of the
crystallography studies with minor discrepancies. In addition, we
studied the roles of residues in and around the HBGA binding site
by structural based mutagenesis analysis and conﬁrmed the binding
site determined by the crystallography study. We also observed that
residues around the core binding sites may inﬂuence the binding
speciﬁcity of this NoV.
Results
Production of GII.10 P particles
The P domain of Vietnam 026 (GII.10) was expressed as a GST
fusion protein (GST–P) in E. coli, which yielded 10 mg/liter
bacteria culture. Digestion of the fusion protein by thrombin
resulted in a mixture of P protein (35 kDa) and GST (26 kDa)
(Fig. 1A, lane C). As expected, gel-ﬁltration analysis of the cleaved
proteins revealed two major peaks with molecular weight of
830 kDa and 50 kDa, respectively (Fig. 1B), each representing
the P particles (830 kDa) and GST dimers (52 kDa) (Fig. 1A).
These data indicated that vast majority of the P protein of Vietnam
026 formed P particles.
Hyperimmune sera against Vietnam 026
Such antisera were produced by immunization of the puriﬁed P
particles to mice (n¼4, see Materials and methods). Highly reactive,
GII.10 NoV antiserawith an average titer of 1:500,000 were obtained
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Fig. 1. Production of P particles of Vietnam 026. (A) SDS-PAGE analysis of P proteins. Lane C, the GST–P fusion protein after cleavage by thrombin. Both P protein (35 kDa)
and GST (26 kDa) are marked with arrows. Fractions of peak 1 and peak 2 were collected from the gel-ﬁltration chromatography (B). Lane M is the prestained protein
standards with bands from the top to bottom being 113, 92, 52, 34, 29, and 21 kDa. (B) Gel-ﬁltration analysis of the GST and P proteins using size-exclusion column Superdex
200 (10/300 GL, GE Healthcare Life Sciences). Two major peaks were seen. Peak 1 was near void volume of the column with a molecular weight of 830 kDa, representing
the P particles of the P protein. Peak 2 was corresponding to a molecular weight of 50 kDa, representing the GST dimers. Four and three fractions of the two peaks were
analyzed by SDS-PAGE (A), which revealed P protein and GST, respectively. The gel-ﬁltration columns were calibrated by the Gel Filtration Calibration Kit (GE Healthcare Life
Sciences) and the recombinant P particles (830 kDa) of NoV (VA387) and GST dimer of S. japonicum (52 kDa). (C) Saliva-based HBGA-binding assays to determine utility and
dilution condition of the pooled mouse antisera against the P particles of Vietnam 026. Four saliva samples representing type A (OH12), B (OH76), O secretor (OH64) and
nonsecretor (OH17) and four different dilutions (1:500, 1:1000, 1:2000 and 1:4000) of pooled sera were tested. Data were the average value of triplicate experiments. All four
saliva samples were Lewis antigen (Lea/Leb/Lex/Ley) positive.
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(data not shown). The utility and dilution of the pooled antisera for an
Elisa assay were determined through saliva-based HBGA-binding
assays using four saliva samples representing types A (OH12), B
(OH76), O (OH64) secretors and nonsecretor (OH17) with high and
low binding capability to the Vietnam 026 P particle (Fig. 1C). The
results showed that the pooled antisera at a dilution of 1:2000 were
able to detect the bound Vietnam 026 P particles and these conditions
were used in all Elisa of this study.
HBGA binding proﬁle of Vietnam 026
We ﬁrst measured the binding of Vietnam 026 P particles to a
panel 113 saliva samples with known blood types that were
collected from the general population of Shenzhen, China (Jin
et al., 2013).The P particles appeared to bind to salivas of all A, B, O
secretors and non-secretors (Fig. 2A), but their binding signals
varied, ranging from high to low. This may be due to different
levels of A, B, and H antigens in the various saliva samples.
Alternatively, HBGAs in the saliva samples other than A, B, H
antigens may also play a role (see below). To address this issue, we
measured the binding of the P particles to a panel of synthetic
oligosaccharides representing 11 different HBGAs. The results
showed that the Vietnam 026 P particles bound strongly to H3,
sialyl Lea, Lea, H1, and Ley, weakly to B, Leb, and H2, but not to A,
Lex, and sialyl Lex antigens (Fig. 2B). These data, together with
those from the crystallographic study (Hansman et al., 2011)
indicated that the determinants of the binding signals of Vietnam
026 to the saliva samples should include the H (types 1 and 3), Lea/
sialyl Lea, Ley, Leb, B, and A antigens. Some discrepancies in
binding results of Vietnam 026 using different approaches were
noted (see Discussion).
The α-1,2-fucose binding site is critical in GII.10 NoV–HBGA
interaction
The crystal structures of the P dimer-HBGA complexes of
Vietnam 026 revealed the α-1,2-fucose interacting site as the core
binding site of the HBGA binding interface (Hansman et al., 2011)
(Fig. 3L). Five amino acids (N355, R356, D385, G451 and Y452)
consistently interact directly with the α-1,2-fucose of all six tested
secretor oligosaccharides (Fig. 3L, orange region). To further
evaluate this site and the roles of the individual residues, alanine
mutations were introduced to four of the ﬁve residues individu-
ally. As expected, all the resulting mutants lost the HBGA-binding
function (Fig. 3A–E), indicating the importance of this α-1,2-fucose
binding site in interaction with HBGAs and that each individual
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Fig. 2. The binding proﬁle of Vietnam 026 to histo-blood group antigens (HBGAs). (A) Binding of Vietnam 026 P particles to a panel of 113 saliva samples (1:1000) from
individuals with different HBGA types. The HBGAs types of the individuals are shown at the bottoms of the panels including type A, B, secretor (Oþ) and non-secretor (O).
(B) Binding of P particle of Vietnam 026 to a panel of synthetic oligosaccharides representing 11 different HBGAs (H1, H2, H3, A, B, Lea, Leb, Lex, Ley, SLex and SLea) (X-axis). All
oligosaccharides were linked to polyacrylamide (PAA)-biotin as backbones. All data were the average value of triplicate experiments.
Fig. 3. Binding of the wild type P particle of Vietnam 026 and its mutants with single amino acid substitution within the binding interface to saliva samples with different
histo-blood group antigens (HBGAs). (A) Binding of the wild type P particle of Vietnam 026 to saliva samples. (B–E) Binding of the mutant P particles with single mutations
in the α-1,2-fucose binding site to saliva samples. (F–I) Binding of the mutant P particles with single mutations in the other saccharide-binding sites to saliva samples. (J, K)
Binding of the mutant P particles with single mutations at K449 to saliva samples. X-axis shows the protein concentration of the P particles and the Y-axis indicates the
optional densities (OD) at 450 nm. Data were the average values of triplicate experiments. (L) The crystal structure (surface representation) of the HBGA-binding interface
of Vietnam 026 (PDB#: 3PA2) with indications of the amino acids that were evaluated by structural-based mutagenesis. The Ley tetrasaccharide is indicated in stick model,
in which the atoms C, O and N are shown in cyan, red and blue, respectively. The four saccharides are labeled as: 1 (α-1,2-fucose), 2 (α-1,3-fucose), 3 (galactose), and 4 (N-
acetyl glucoseamine), respectively. The α-1,2-fucose binding site is shown in orange. Amino acids that are involved in interactions with other saccharides are shown in
green and red. Underlined amino acids are from the other P domain protomer.
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amino acid is indispensable for the structural integrity of this
binding site.
Importance of other saccharide-binding sites
Some other amino acids are also involved in interaction with
saccharides of the HBGAs other than the α-1,2-fucose, including
W381, E382, A400, and S401(Hansman et al., 2011) (Fig. 3L, green
region). Mutation of W381, E382 and S401 into an alanine,
respectively, abolished the binding function of the three mutants
(Fig. 3F, G and I), indicating that these three amino acids are
required for the structural integrity of the binding interface. One
exception is the A400S mutant that decreased, but remained well-
bound to HBGAs (Fig. 3H). This residue is involved in interaction
with the Ley tetrasaccharide through the GlcNAc of the precursor
disaccharide (Hansman et al., 2011).
Mutation of K449 changed binding speciﬁcity
The K449 interacts with A, B and H, but not to Lewis antigens
(Hansman et al., 2011) (Fig. 3L, red region). Interestingly, K449A
mutant exhibited a HBGA-binding pattern distinct from the wild
type one (Fig. 3, compare A and J), in which K449A mutant
decreased binding to saliva sample of OH 12 (type A) signiﬁcantly
but increased binding to OH 76 saliva (type B). However, the
K449R mutant lost binding to all saliva samples (Fig. 3K), although
both K and R are positive charged amino acids. This data indicate
complex roles of the K449 in the binding function and as factor of
binding speciﬁcity of GII.10 NoV. Oligosaccharide-based HBGA
binding assays were performed to further characterize the binding
speciﬁcity of the K449A mutant. The results (Fig. 4A) showed that
the K449A mutant indeed increased binding to B antigen signiﬁ-
cantly compared with the wild type Vietnam 026 P particles, while
it also exhibited decreased binding to H1, Lea and sialyl Lea antigen
at certain levels (Fig. 4A). To conﬁrm these observations extended
saliva-based binding assays were also carried out, which revealed
the increased signal intensities of the K449A mutant accumulating
to the B and AB type salivas (Fig. 4B). When the results were
organized by the signal intensity of the B antigens, consistently
high signals of K449A mutant were seen when any B antigen is
detected in the saliva sample (Fig. 4C).
Residues around the binding interface contribute to the binding
function differently
To further investigate effects of the residues around the binding
interface we selected residues A354, A357, H358, G450 within the
region of the binding interface, as well as E359 and R299 outside
the direct region of the binding interface for mutagenesis (Fig. 5H).
Mutations of these residues to an alanine (or serine) individually
revealed different effects (Fig. 5). Mutants A354S, H358A and
G450A, representing three of the four residues within the region
of the binding interface lost their binding to HBGAs (Fig. 5B, D and
E), while mutant A357S (Fig. 5C), the remaining residue within the
region of the binding interface, did not reduce signiﬁcantly
compared with the wild type P particles. As expected, mutations
at the two residues (R229 and E359) that are away from the
binding interface (Fig. 5H) into alanine, respectively, did not affect
the binding capability of the mutant P particles (Fig. 5F and G). In
fact, E359A mutant even showed some increased binding signal
compared with the wild type P particles. These data suggested that
residues around the binding interface contribute to the binding
function differently.
Discussion
Increasing data suggest that NoV–HBGA interactions correlate
with the host susceptibility of NoV infection and illness, making it
important to determine HBGA-binding proﬁles of individual strains
for epidemiology assessment of NoV diseases. In addition, a recent
study showed that H antigen or HBGA-expressing bacteria promoted
replication of a human NoV in the BJAB B cell line (Jones et al., 2014),
further highlighting the importance of HBGAs in NoV infection and
replication. We characterized in this study the strain-speciﬁc
NoV–HBGA interaction of a GII.10 NoV, Vietnam 026, in which the
HBGA-binding proﬁle was determined and the roles of the amino
acids in and around the HBGA-binding interface were evaluated. Our
data, together with those known previously (Hansman et al., 2011),
showed that Vietnam 026, an isolate of the genotype GII.10, bound
H3/H1, A, B, Ley, Lea and sialyl Lea antigens. Accordingly, saliva-based
binding assays using a panel of saliva samples from 113 individuals
also showed interactions of this NoV to salivas of A, B, O secretor and
nonsecretor types, although the binding signals varied. These data
raised a question on how to interpret the HBGA binding proﬁle of
Vietnam 026 to the low prevalence of GII.10 NoVs. The binding signals
of Vietnam 026 P particles to saliva samples appeared to be low in
general, which might be a factor for the low prevalence of the
GII.10 NoV.
The HBGA-binding proﬁle of Vietnam 026 that binds strongly to
H3, Lea/sialyl Lea, H1, Ley, and weakly to B, Leb, and H2 antigens
determined by the conventional binding assays in this study is
similar but also different compared with the one determined by
co-crystallization study (Hansman et al., 2011). The failure to
measure the binding of Vietnam 026 P particle to type A oligosac-
charide by a binding assay may be due to a problem of the reagent of
the type A oligosaccharide. The difference may be due to distinct
methodology of the two studies. For example, co-crystallizations of
the P dimers with oligosaccharide HBGAs were performed using
extremely high concentrations of both the P protein (2–10 mg/ml)
and oligosaccharides (30–60 molar folds excess that of the P protein)
(Hansman et al., 2011). This experimental setup would record very
weak interactions between these two reagents. In fact, using the
direct electrospray ionization mass spectrometry (ESI-MS) a recent
study showed that the P dimers of VA387, a GII.4 NoV, bound to all
41 tested HBGAs representing all types 1 to 6A, B, H epitopes and
Lewis antigens (Han et al., 2012), although conventional saliva- and
oligosaccharide-based binding assays recorded only binding to
certain secretor antigens (Huang et al., 2003; Huang et al., 2005).
Since native NoV infection are normally caused by NoV contami-
nated food, water or surface, which is known for low dose, the
conventional binding assays with low concentration of NoV capsid
proteins might be better reﬂex NoV transmission in the real world
which is comparable with the literatures.
The crystal structures of the HBGA-binding interfaces have
been solved in three GI (Bu et al., 2008; Choi et al., 2008; Kubota
et al., 2012; Shanker et al., 2014) and ﬁve GII (Bu et al., 2008; Cao
et al., 2007; Chen et al., 2011; Hansman et al., 2011; Shanker et al.,
2011) NoVs. The roles of amino acids in and around the HBGA-
binding interfaces have also been studied in some of the above
NoVs through structure-guided mutagenesis (Bu et al., 2008; de
Rougemont et al., 2011; Kubota et al., 2012; Tan et al., 2008c; Tan
et al., 2009). In this study, we systematically evaluated 16 amino
acids in and around the HBGA-binding interface of a GII.10 NoV
(Vietnam 026) for their roles in NoV–HBGA binding. In summary
of the data, two general phenomena are seen, (1) conservation of
the HBGA-binding interface and (2) ﬂexibility of the HBGA-binding
function. The conservation of the HBGA-binding interface is shown
by the conserved amino acids constituting the core structure of
the central binding pocket (Tan and Jiang, 2014). Any mutation of
these amino acids completely abolished the binding function. In
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strain Vietnam 026, amino acids R356, D385, W381, and E382 are
these conserved residues which are essential for HBGA binding
function and therefore for viability of the strain. On the other
hand, the ﬂexibility of the HBGA-binding function is shown by the
fact that mutations of certain amino acids around the core
structure of the binding sites change the HBGA binding proﬁles
of the mutants. The residue K449 of Vietnam 026 is such a ﬂexible
amino acid. The ﬂexibility could potentially allow NoV mutants to
establish replications in new target populations. It should also be
noted that the mutant K449R lost its binding completely, suggest-
ing that different mutations at the same amino acid could lead to
different outcomes, making the conservation/ﬂexibility features
more complicated.
In addition to the amino acids that interact directly with the
HBGAs as revealed by the crystallography (Hansman et al., 2011),
we have identiﬁed three other amino acids (A354, A357 and H358)
that are not directly involved in the interaction with HBGAs, but
play an important role for HBGA-binding function. Mutation of
these residues to an alanine or serine wiped out the binding
function completely. Thus, these residues may contribute to the
conformational integrity of the HBGA binding interface.
In summary, our study established the HBGA-binding proﬁle of a
rare GII.10 NoV, providing new information to the relationship
between the HBGA-binding property and the epidemiology outcome
of NoVs. In addition, the systematic analysis of the individual residues
in and around HBGA binding site shed light into the complex
interaction between the diverse NoVs and the polymorphic HBGAs.
Materials and methods
Expression constructs of wild type and mutant P particles of Vietnam 026
The P domain-encoding cDNA sequences of Vietnam 026 (GII.10)
(GenBank Accession no.AF504671, amino acid sequences from 222 to
557 of VP1 were used) were synthesized (GenScript, Piscataway, NJ)
and cloned into the expression vector pGEX-4T-1 (GE Healthcare Life
Sciences) between the BamHI and Not I sites. A cysteine containing
short peptide (CDCRGDCFC) was added to the C-terminal end of the P
domain to facilitate the P particle formation as described previously
(Tan et al., 2008a; Tan and Jiang, 2005b). Mutant P particles with a
single amino acid mutation at the HBGA binding interface (Table 2) or
0
0.5
1
1.5
2
2.5
3
3.5
27 6 42 95 34 31 65 13 10
9 60 68 54 11 48 45 93 77 5 22 10
4
11
6 21 55 29 9 90 10
0 84 88 16 7 92 98 14 30 12 26 50 10
2 10 39 70 20 63 10
8 72 80 83 36 10
6 33 23 97 11
0 32 2 86
Wild type P particle K449A
0
0.5
1
1.5
2
2.5
3
3.5
26 13 10
7 48 10
5 35 52 50 24 11
4 72 23 53 11
5 60 10
6 45 11
0 41 11 77 27 83 2 81 33 58 31 54 5 95 10
2 32 44 16 87 98 66 74 70 80 18 67 94 97 19 84 55 46 9 49 85 91 8 90 10
0 21
B Wild type P particle K449A
(Oligosaccharides/HBGAs)
OD
OD
OD
A           B         AB     O+                    O-
(Saliva)
(Saliva)
0
0.5
1
1.5
2
2.5
Lea Leb Laex Ley A B H1 H2 H3 Slea Slex
Wild type P particle
K449A
Fig. 4. Binding of Vietnam 026 wild type and K449A mutant to histo-blood group antigens (HBGAs). (A) Binding of the wild type and K449A mutant P particles to a panel of
synthetic oligosaccharides representing 11 different HBGAs (H1, H2, H3, A, B, Lea, Leb, Lex, Ley, SLex and SLea) (X-axis). All oligosaccharides were linked to polyacrylamide
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types of the individuals are shown at the bottoms of the panels including type A, B, secretor (Oþ) and non-secretor (O). (C) Data from (B) were organized according to the
ascending of the signal intensity of B antigens. All data were average values of triplicate experiments.
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Fig. 5. Binding of the wild type P particle of Vietnam 026 and its mutants with single amino acid substitution within or around the binding interface to saliva samples with
different histo-blood group antigens (HBGAs). (A) Binding of the wild type P particle of Vietnam 026 to saliva samples. (B–E) Binding of the mutant P particles with single
mutations within the HBGA-binding interface to saliva samples. (F, G) Binding of the mutant P particles with single mutations around the HBGA-binding interface to saliva
samples. (H) The crystal structure (surface representation) of the HBGA-binding interface of Vietnam 026 (PDB#: 3PA2) with indications of the amino acids within or around
the HBGA-binding interface. The Ley tetrasaccharide is indicated in stick model, in which the atoms C, O and N are shown in cyan, red and blue, respectively. The four
saccharides are labeled as: 1 (α-1,2-fucose), 2 (α-1,3-fucose), 3 (galactose), and 4 (N-acetyl glucoseamine), correspondingly. The labeled amino acids are not directly involved
in interactions with HBGAs. The residues that are involved in HBGA-binding directly are shown in orange (α-1,2-fucose binding site), green and red. Underlined amino acids
are from the other P domain protomer.
M. Jin et al. / Virology 476 (2015) 386–394392
surrounding area were constructed based on the wild type construct
as template through site-directed mutagenesis approach using the
QuickChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA)
and the corresponding primers (Table 1) as described elsewhere (Tan
et al., 2008c; Tan et al., 2009). The mutations were conﬁrmed by DNA
sequencing.
Production of wild type and mutant P particles of Vietnam 026
The wild type and mutant P particles were expressed and puriﬁed
as described previously (Tan et al., 2004a; Tan and Jiang, 2005b).
Brieﬂy, after sequence conﬁrmation the P proteins were expressed in
E. coli strain BL21 with IPTG (0.5 mM) induction at room temperature
(25 1C) overnight. The P protein–GST fusion proteins were puriﬁed
using the Glutathione Sepharose 4 ﬂow (GE Healthcare Life Sciences)
according to the manufacturer's protocol. The P proteins were released
from GST by thrombin (GE Healthcare Life Sciences) digestion. The
formation of the P particle was determined by gel-ﬁltration using a
size-exclusion column Superdex 200 (GE Healthcare Life Sciences)
powered by an AKTA-FPLC system (model 920, GE Healthcare Life
Science), in which the P particles formed a peak at 830 kDa and the
P dimer at 69 kDa, respectively (Tan et al., 2004a; Tan and Jiang,
2005b; Tan et al., 2006). All mutant P particles that were created in
this study with single residue mutation at or near the HBGA binding
interface do not change their P particle formation as shown by gel-
ﬁltration chromatography (see below).
Production of GII.10 mouse antisera
The puriﬁed wild type P domain protein (P particles) of Vietnam
026 was immunized to mice intranasally without adjuvant at a dose
of 25 mg/mouse (N¼4) four times at two-week intervals. Sera were
prepared from bloods that were collected before the ﬁrst immuni-
zation and two weeks after the ﬁnal immunization. These antisera
were used for detection of Vietnam 026 P particle that bound to the
coated HBGAs (see below).
Gel-ﬁltration chromatography
This was performed through an Akta Fast Performance Liquid
Chromatography (FPLC) system (model 920, GE Healthcare Life
Sciences) using a size exclusion column (Superdex 200, 10/300 GL
with 24 ml bed volume, GE Healthcare Life Sciences), as described
previously (Tan et al., 2004a; Tan and Jiang, 2005c; Tan et al.,
2004b). The columns were calibrated using gel-ﬁltration calibra-
tion kits (GE Healthcare Life Sciences) and the puriﬁed NoV P
particle (830 kDa) of NoV VA387 (Tan and Jiang, 2005c) and GST
dimer of S. japonicum (50 kDa). The protein identities in the
peaks of interest were further analyzed by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE).
SDS-PAGE and protein concentration determination
Recombinant proteins were analyzed by SDS-PAGE using freshly
prepared 10% separating gels. Protein concentrations were deter-
mined on SDS-PAGE using diluted bovine serum albumin (BSA,
Bio-Rad) with known concentration as standards.
HBGA binding assay
The saliva- and synthetic-oligosaccharide based binding assays
were performed basically as described previously (Huang et al.,
2003; Huang et al., 2005). The afﬁnity-column puriﬁed P particles
were ﬁrst diluted to 0.5 mg/ml as starting solutions, then they were
diluted further in a 2-fold-series to 6 μg/ml, 3 μg/ml, 1.5 μg/ml and
0.75 μg/ml directly on the Elisa plates, on which saliva- or
synthetic-oligosaccharides have been coated. The saliva samples
used in this study were well-deﬁned in our laboratory (Huang et al.,
2003; Huang et al., 2005). The synthetic oligosaccharide-based
binding assays were performed using a panel of oligosaccharides
representing 10 different HBGAs (B, H1, H2, H3, Lea, Leb, Lex, Ley,
sialyl Lea and sialyl Lex) as reported previously (Huang et al., 2003;
Huang et al., 2005). The detection antibody was the pooled mouse
antisera after immunization with Vietnam 026 P particle (see
above) at a dilution of 1:2000. The bound antibodies were detected
by HRP-conjugated goat anti-mouse secondary antibody (MP Bio-
medicals, Inc.)(1:3000). Saliva samples were boiled and diluted
1000 , while the synthetic oligosaccharides were at 2 mg/ml for
coating the plates.
Table 1
Primers used for site-directed mutagenesis to generate single amino acid mutation.
# Name Primer sequence (50 to 30) Sense Mutation
1 P1742 GGTAACCTGCCGGCTGCCCGTGCTCACGAAGCTG þ N355A
2 P1743 CAGCTTCGTGAGCACGGGCAGCCGGCAGGTTACC  N355A
3 P1744 GGTAACCTGCCGGCTAACGCTGCTCACGAAGCTG þ R356A
4 P1745 CAGCTTCGTGAGCAGCGTTAGCCGGCAGGTTACC  R356A
5 P1746 ATCCAGTTCTCTACCGCGGAAACCCAGGACGTTTC þ W381A
6 P1747 GAAACGTCCTGGGTTTCCGCGGTAGAGAACTGGAT  W381A
7 P1748 CAGTTCTCTACCTGGGCAACCCAGGACGTTTCTTC þ E382A
8 P1749 GAAGAAACGTCCTGGGTTGCCCAGGTAGAGAACTG  E382A
9 P1750 ACCTGGGAAACCCAGGCCGTTTCTTCTGGTCAG þ D385A
10 P1751 CTGACCAGAAGAAACGGCCTGGGTTTCCCAGGT  D385A
11 P1752 ACCCCGGTTGGTCTGTCTTCTGTTGACGCTAAC þ A400S
12 P1753 GTTAGCGTCAACAGAAGACAGACCAACCGGGGT  A400S
13 P1754 CCGGTTGGTCTGGCTGCTGTTGACGCTAACTCTC þ S401A
14 P1755 GAGAGTTAGCGTCAACAGCAGCCAGACCAACCGG  S401A
15 P1756 TCTTTCATCCCGCTGGCAGGTGGTTACGGTAAC þ K449A
16 P1757 GTTACCGTAACCACCTGCCAGCGGGATGAAAGA  K449A
17 P1758 ATCCCGCTGAAAGGTGCTTACGGTAACCCGGC þ G451A
18 P1759 GCCGGGTTACCGTAAGCACCTTTCAGCGGGAT  G451A
19 P1760 CCGCTGAAAGGTGGTGCCGGTAACCCGGCTATC þ Y452A
20 P1761 GATAGCCGGGTTACCGGCACCACCTTTCAGCGG - Y452A
Table 2
Summary of the systematic mutagenesis analysis on residues in and around the
HBGA-binding interface of NoV strain Vietnam 026.
Mutantsa Relative binding afﬁnity to HBGAsb
P particlesc
Oþ O A B
Wild type   þ þ
N355A*    
R356A*    
A357S þþ þþ þþ þþ
D385A*    
K449A*   þ þþþþ
K449R*    
G451A*& ND ND ND ND
Y452A*    
W381A*    
E382A*    
S401A*    
A400S*   þþ þ
A354S    
H358A    
E359A   þþþþ þþþþ
R299A þ þþ þþ þþþ
a Amino acids with a star symbol are predicted to interact with Ley and Leb
tetrasaccharide, H-2, Leb A- and/or B trisaccharides and H-2 disaccharide by
crystallographic study.
b Number of “þ” indicated the relative binding afﬁnity of the mutant P
particles to HBGAs. “” indicated a complete loss of binding.
c The P particle formation of wild type and all mutants were conﬁrmed by gel-
ﬁltration.
& ND: not determined.
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Crystal structure visualization and analysis
The crystal structures of the P dimer of Vietnam 026 in complex
with different oligosaccharides were analyzed using the PyMOL
software (DeLano Scientiﬁc LLC, Palo Alto, CA). The PDB ﬁles of
Vietnam 026 were downloaded from the Protein Data Bank at the
Rutgers University, New Brunswick, NJ (http://www.rcsb.org).
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